9% HEN GJ-Tuesday Tube Facts

Did you know…?

Nearly 9% of home enteral nutrition (HEN) patients have a gastrojejunostomy (GJ) tube.[1]

This is compared to more than 75% of HEN patients that have a gastrostomy (G) tube.[1]


  1. Guenter, P., Read, J. ASPEN Enteral Nutrition by the Numbers: EN Data Across the Healthcare Continuum. American Society for Parenteral and Enteral Nutrition. 2017.

HEN Proactive Enzymes-Tuesday Tube Facts

Did you know…?

In one study of home enteral nutrition (HEN) patients, using an enzyme declogger proactively did not reduce the likelihood of clogged feeding tubes.[1]

In the study, 29% of the control group (using standard of care to maintain their feeding tubes) experienced a clog while 39% of those in the study group (using an enzyme product prophylactically) experienced a clog.[1]


  1. Escuro, A.A., Burns, B., McLaughlin, K., Lopez, R. and Cresci, G.A. (2020), Dietitians’ Evaluation of Clearing Luminal Occlusions of Gunk (DECLOG): A Pilot Feasibility Study. Nutrition in Clinical Practice, 35: 142-148. doi:10.1002/ncp.10318.

Clog Require Intervention-Tuesday Tube Facts

Did you know…?

In one study of Home Enteral Nutrition (HEN) patients, feeding tube dysfunction (including clogging) was the most common complication requiring intervention by a healthcare provider.[1]

The study found that 25% of HEN patients experienced a clogged feeding tube.[1]


  1. Crosby, J. and Duerksen, D.R. (2007), A Prospective Study of Tube‐ and Feeding‐Related Complications in Patients Receiving Long‐Term Home Enteral Nutrition. JPEN J Parenter Enteral Nutr, 31: 274-277. doi:10.1177/0148607107031004274

61% HEN Clogging-Tuesday Tube Facts

Did you know…?

In one study of Home Enteral Nutrition (HEN) patients, only 39% never experienced a clogged feeding tube.[1]

Feeding tubes less than 14 French in diameter were more likely to clog than those larger than 14 French.[1]


  1. Epp, L.M., Salonen, B.R., Hurt, R.T. and Mundi, M.S. (2019), Cross‐sectional Evaluation of Home Enteral Nutrition Practice in the United States in the Context of the New Enteral Connectors. Journal of Parenteral and Enteral Nutrition, 43: 1020-1027. doi:10.1002/jpen.1510

TubeClear Receives FDA Clearance for New GJ-Specific Clearing Stem Model

TubeClear Receives FDA Clearance for New GJ-Specific Clearing Stem Model

BELLEFONTE, PA – Actuated Medical, Inc. (AMI) recently received its sixth Food and Drug Administration (FDA) 510(k) clearance for the TubeClear® system. Clearance number K200646 introduces a Clearing Stem model that is compatible with select gastro-jejunostomy (GJ) feeding tubes.

These complex dual lumen feeding tubes are often expensive and require surgery to place. When a clogged feeding tube of any type cannot be cleared, it requires replacement. The new TubeClear GJ-1422 Clearing Stem offers a mechanical option for clinicians to keep these expensive GJ tubes clear and avoid an unnecessary procedure to replace the tube. The GJ-1422 Clearing Stem is designed to work with MIC*, MIC-KEY* (Avanos Medical, Inc., Alpharetta, GA) and G-Jet® (Applied Medical Technology (AMT), Brecksville, OH) GJ feeding tubes that are 14-22 French diameter and have a jejunal length of 15-45 centimeters.

“Clogging in GJ tubes is one of the most common complaints we hear from clinicians and patients alike,” said AMI president and chief executive officer Maureen L. Mulvihill, PhD. “Being able to deliver a Clearing Stem that is compatible with our existing TubeClear system as well as GJ feeding tubes is an exciting opportunity for AMI to support vulnerable patients and improve their outcomes.”

The TubeClear system is an FDA cleared medical device that uses patented mechanical motion technology to maintain flow and clear clogs in most feeding and decompression tubes while the tube remains in the patient and works at bedside. Keeping these tubes clear prevents interruptions to feeding and medication delivery, allowing clinicians to maintain their focus on improving patient care and reducing healthcare cost associated with tube replacement. The system, which is comprised of reusable control boxes and single-use clearing stems, is designed, developed, and manufactured by AMI in Bellefonte, PA. The new GJ Clearing Stem is slated to be available for sale in clinical settings in early 2021.



About Actuated Medical, Inc.

Actuated Medical develops medical devices that integrate electronically controlled motion technologies that improve patient outcomes and reduce healthcare costs. Their development process focuses on intellectual property, regulatory, and reimbursement strategies to decrease commercialization risk and attract medical device technology licensing partnerships. Their devices solve unmet clinical needs in target markets (e.g., GI, oncology, critical care and pediatrics). Actuated Medical a certified women-owned business located in Bellefonte, PA and is ISO 13485:2016 certified.

For more information, please visit http://www.actuatedmedical.com